 WATERTOWN, Mass.--BUSINESS WIRE--SQZ Biotechnologies NYSE: SQZ, focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced the appointments of Bernard Coulie, M.D., Ph.D., and Patrick Vink, M.D., to its board of directors, adding global commercial and clinical development expertise. We are thrilled to have Bernard and Patrick join our Board, said Armon Sharei, Ph.D., Chief Executive Officer and Founder of SQZ Biotechnologies. As we execute o 